PHARMAC have announced CGM funding for people with Type 1 diabetes from 1 October 2024. More detail to come.Additional information on Diabetes New Zealand website and the Pharmac Websites
You have nothing in your cart.
If you know the product code enter it here
If you know the product code enter it into the search field
Recombinant Human Flt-3 Ligand (Animal-Free), 10 μg
Recombinant Human FLT3L (carrier-free), 10 μg
Recombinant Human FLT3L (carrier-free), 100 μg
Recombinant Human FLT3L (carrier-free), 25 μg
Recombinant Human FLT3L (carrier-free), 500 μg
Recombinant Human Furin (carrier-free), 10 μg
Recombinant Human Furin (carrier-free), 100 μg
Recombinant Human Furin (carrier-free), 25 μg
Recombinant Human FXI (carrier-free), 10 μg
Recombinant Human FXI (carrier-free), 25 μg
Recombinant Human Galectin-1 (carrier-free), 100 μg
Recombinant Human Galectin-1 (carrier-free), 25 μg
Recombinant Human Galectin-3 (carrier-free), 100 μg
Recombinant Human Galectin-3 (carrier-free), 25 μg
Recombinant Human Galectin-9 (carrier-free), 10 µg
Recombinant Human Galectin-9 (carrier-free), 100 µg